Myocardial Steatosis Among Antiretroviral Therapy–Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial

BACKGROUND: People with human immunodeficiency virus (PWH) face increased risks for heart failure and adverse heart failure outcomes. Myocardial steatosis predisposes to diastolic dysfunction, a heart failure precursor. We aimed to characterize myocardial steatosis and associated potential risk fact...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Dis
Main Authors: Neilan, Tomas G, Nguyen, Kim-Lien, Zaha, Vlad G, Chew, Kara W, Morrison, Leavitt, Ntusi, Ntobeko A B, Toribio, Mabel, Awadalla, Magid, Drobni, Zsofia D, Nelson, Michael D, Burdo, Tricia H, Van Schalkwyk, Marije, Sax, Paul E, Skiest, Daniel J, Tashima, Karen, Landovitz, Raphael J, Daar, Eric, Wurcel, Alysse G, Robbins, Gregory K, Bolan, Robert K, Fitch, Kathleen V, Currier, Judith S, Bloomfield, Gerald S, Desvigne-Nickens, Patrice, Douglas, Pamela S, Hoffmann, Udo, Grinspoon, Steven K, Ribaudo, Heather, Dawson, Rodney, Goetz, Matthew Bidwell, Jain, Mamta K, Warner, Alberta, Szczepaniak, Lidia S, Zanni, Markella V
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Supplement Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7347082/
https://ncbi.nlm.nih.gov/pubmed/32645158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa245
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados